載入...
FDA Approvals of Brand-Name Prescription Drugs in 2015
I. New Pharmaceuticals: New Molecular Entities and New Biologic License Applications. II. New Combinations and New Indications. III. New Dosage Forms and New Formulations. IV. New Biosimilars, Vaccines, Viral Therapies, and Blood Products.
Na minha lista:
| 發表在: | Am Health Drug Benefits |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Engage Healthcare Communications, LLC
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5013848/ https://ncbi.nlm.nih.gov/pubmed/27668042 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|